Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: genOway

Market Cap 24.99M 28.92M 23M 21.56M 40.41M 2.75B 41.06M 273M 106M 1.34B 109M 106M 4.63B P/E Ratio 2023 *
-
P/E Ratio 2024 -
Enterprise Value 25.61M 29.65M 23.57M 22.1M 41.42M 2.82B 42.08M 280M 109M 1.37B 111M 109M 4.75B EV / Sales 2023
1.64x
EV / Sales 2024 1.28x
Free-Float
79.77%
Yield 2023 *
-
Yield 2024 -
1 day-0.83%
1 week+0.42%
Current month+0.42%
1 month-4.00%
3 months+2.13%
6 months-2.83%
Current year-11.44%
1 week 2.39
Extreme 2.39
2.5
1 month 2.33
Extreme 2.33
2.52
Current year 2.18
Extreme 2.18
2.79
1 year 2.1
Extreme 2.1
3.5
3 years 2.1
Extreme 2.1
4.91
5 years 2.1
Extreme 2.1
4.91
10 years 1
Extreme 1
7.7
Manager TitleAgeSince
Chief Executive Officer - -
Chief Operating Officer - 01/03/1999
Director of Finance/CFO - 01/10/2015
Director TitleAgeSince
Director/Board Member - 01/03/1999
Chairman - -
Director/Board Member - -
Date Insider Type Main position Quantity % Market Cap.
20/01/22Buy

Chief Executive Officer

12,500 0.1376%
17/11/21Sell

Chief Executive Officer

5,000 0.0553%
13/11/21Sell

Founder

1,147 0.0127%
Change 5-day change 1-year change 3-year change Capi.($)
-0.83%+0.42%-31.23%-38.78% 25.78M
-1.40%+0.63%-14.67%-12.58% 43.68B
+3.50%-4.33%+255.48%+484.30% 30.65B
-0.61%-0.54%+13.33%-12.36% 30.4B
-1.27%-6.71%-1.20%+20.47% 29.31B
-0.66%-7.13%+7.59%+12.76% 24.2B
+2.01%+5.38%+55.30%+128.55% 13.3B
+2.77%-0.55% - - 13.03B
-1.65%+4.14%+9.38%+7.56% 13.21B
+0.68%0.00%+100.38%+81.60% 12.12B
Average +0.05%-0.74%+43.82%+74.61% 20.99B
Weighted average by Cap. -0.02%-1.44%+49.87%+89.53%

Financials

2023 2024
Net sales 26.51M 30.69M 24.4M 22.88M 42.87M 2.92B 43.56M 290M 113M 1.42B 115M 113M 4.91B 27.53M 31.87M 25.34M 23.76M 44.53M 3.03B 45.24M 301M 117M 1.47B 120M 117M 5.1B
Net income 1.57M 1.81M 1.44M 1.35M 2.54M 173M 2.58M 17.12M 6.66M 83.96M 6.82M 6.67M 290M 1.83M 2.12M 1.68M 1.58M 2.96M 202M 3.01M 20M 7.77M 98.06M 7.96M 7.79M 339M
Net Debt 2.97M 3.44M 2.74M 2.57M 4.81M 328M 4.88M 32.47M 12.62M 159M 12.93M 12.65M 551M 623K 721K 573K 538K 1.01M 68.67M 1.02M 6.8M 2.64M 33.37M 2.71M 2.65M 115M
Logo genOway
genOway est une société de biotechnologie spécialisée dans la conception et le développement de modèles de recherche moléculaires, cellulaires et animaux à forte valeur ajoutée pour les industries biopharmaceutique, chimique, agrochimique et agroalimentaire ainsi que pour la recherche académique. genOway est une société leader sur son marché. Elle appuie son développement sur la combinaison d'une large et exclusive plateforme technologique et d'une propriété intellectuelle forte combinant brevets et licences d'exploitation. genOway a conclu de nombreux contrats commerciaux avec les leaders de l'industrie pharmaceutique (BMS, Janssen, Novartis, Pfizer, etc.), et avec les centres de recherche académiques les plus prestigieux (King's College et Université de Manchester en Angleterre, Harvard, Caltech et le National Institute of Health aux Etats-Unis, l'Institut Pasteur en France, le NGFN et l'Institut Max Planck en Allemagne, etc.).
Employees
148
Date Price Change Volume
11/06/26 2.400 -0.83% 1,224
10/06/26 2.420 -0.41% 2,941
09/06/26 2.430 0.00% 2,067
08/06/26 2.430 -0.82% 3,130
05/06/26 2.450 -2.00% 4,758
  1. Stock Market
  2. Stocks
  3. ALGEN Stock
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!